seed
Stage
1
Investors
About
CasInvent develops proprietary highly selective inhibitors of Casein Kinase 1 (CK1) enzymes targeting treatment-resistant tumors, with a focus on cancers such as Acute Myeloid Leukemia and various solid tumors.
Explore CasInvent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.